Abstract:Background: Deep learning has always been at the forefront of scientific research. It has also been applied to medical research. Hereditary spinocerebellar ataxia (SCA) is characterized by gait abnormalities and is usually evaluated semi-quantitatively by scales. However, more detailed gait characteristics of SCA and related objective methods have not yet been established. Therefore, the purpose of this study was to evaluate the gait characteristics of SCA patients, as well as to analyze the correlation between gait parameters, clinical scales, and imaging on deep learning. Methods: Twenty SCA patients diagnosed by genetic detection were included in the study. Ten patients who were tested via functional magnetic resonance imaging (fMRI) were included in the SCA imaging subgroup. All SCA patients were evaluated with the International Cooperative Ataxia Rating Scale (ICARS) and Scale for the Assessment and Rating of Ataxia (SARA) clinical scales. The gait control group included 16 healthy subjects, and the imaging control group included seven healthy subjects. Gait data consisting of 10 m of free walking of each individual in the SCA group and the gait control group were detected by wearable gait-detection equipment. Stride length, stride time, velocity, supporting-phase percentage, and swinging-phase percentage were extracted as gait parameters. Cerebellar volume and the midsagittal cerebellar proportion in the posterior fossa (MRVD) were calculated according to MR. Results: There were significant differences in stride length, velocity, supporting-phase percentage, and swinging-phase percentage between the SCA group and the gait control group. The stride length and stride velocity of SCA groups were lower while supporting phase was longer than those of the gait control group. SCA group's velocity was negatively correlated with both the ICARS and SARA scores. The cerebellar volume and MRVD of the SCA imaging subgroup were significantly smaller than those of the imaging control group. MRVD was significantly correlated with ICARS and SARA scores, as well as stride velocity variability. Conclusion: SCA gait parameters were characterized by a reduced stride length, slower walking velocity, and longer supporting phase. Additionally, a smaller cerebellar volume correlated with an increased irregularity in gait. Gait characteristics exhibited considerable clinical relevance to hereditary SCA. We conclude that a combination of gait parameters, ataxia scales, and MRVD may represent more objective markers for clinical evaluations of SCA.

Visual Prediction of the Progression of Spinocerebellar Ataxia Type 3 Based on Machine Learning

Gait characteristics and clinical relevance of hereditary spinocerebellar ataxia on deep learning

Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine Learning

Explainable Artificial Intelligence Based on Feature Optimization for Age at Onset Prediction of Spinocerebellar Ataxia Type 3.

The Progression Rate of Spinocerebellar Ataxia Type 3 Varies with Disease Stage

New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3

MR Imaging of SCA3/MJD

Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study

Pattern of Cerebellar Grey Matter Loss Associated with Ataxia Severity in Spinocerebellar Ataxias Type 3: a Multi-Voxel Pattern Analysis

Related Factors of ICARS and SARA Scores on Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

Assessing clinical progression from subjective cognitive decline to mild cognitive impairment with incomplete multi-modal neuroimages

Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression

Machine Learning Algorithms for Early Prediction of Multiple Sclerosis Progression: A Comparative Study

Interpretable and Intuitive Machine Learning Approaches for Predicting Disability Progression in Relapsing-Remitting Multiple Sclerosis Based on Clinical and Gray Matter Atrophy Indicators

Potential Fluid Biomarkers and a Prediction Model for Better Recognition Between Multiple System Atrophy-Cerebellar Type and Spinocerebellar Ataxia

An interpretable data-driven prediction model to anticipate scoliosis in spinal muscular atrophy in the era of (gene-) therapies

Personalized Progression Modelling and Prediction in Parkinson’s Disease with a Novel Multi-Modal Graph Approach

Insight into the early pathogenesis and therapeutic strategies of spinocerebellar ataxia type 3/machado–joseph disease from mouse models

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression

Spinocerebellar Ataxia Type 3 Pathophysiology—Implications for Translational Research and Clinical Studies